Vera Therapeutics appointed Amgen and Seagen alum Matt Skelton as EVP of commercial. Frank Lane was appointed SVP and head of ...

Sanofi also rejected the idea that Gilles Schnepp — one of the US buyout firm’s operating advisers who has been a Sanofi board member since 2020 — presented a conflict of interest.

French public investment bank Bpifrance is expected to become a minority shareholder, taking a stake of around 2%, said Sanofi in a statement, and giving the state a seat on Opella's board.

Julien Dodet President of the Governing Board, Orano Med “Sanofi ... as well as gastrointestinal and lung cancers. Sanofi and Orano Med are members of the Paris Saclay Cancer Cluster and ...

PARIS, Oct 16 (Reuters) - French unions have called on workers at Sanofi (SASY.PA), opens new tab to strike from Thursday to protest a planned sale of the pharmaceutical group's consumer health ...

Sanofi SAN-0.92%decrease; red down pointing triangle is in discussions with the French government to address concerns officials raised about a potential sale of a controlling stake in the company ...

president of Orano Med’s governing board, said in the release. “We look forward to combining Sanofi’s expertise with our R&D and world-class radiopharmaceutical capabilities to advance the ...

Sanofi SAN-1.01%decrease; red down pointing triangle moved ahead with a plan to sell a controlling stake in its consumer-healthcare unit Opella to Clayton Dubilier & Rice, entering exclusive talks ...

PARIS (Reuters) -Sanofi on Sunday reached an agreement on ... Bpifrance would take a 1% stake in Opella and hold a seat on the board. "We have obtained guarantees that Opella stays and develops ...

(Bloomberg) -- After a year-long takeover battle for the owner of France’s best-selling painkiller, Sanofi’s decision to sell its over-the-counter business to a US buyout firm descended into ...